Rheumatology Doctors in Scranton, PA Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Mr. Mark Cruciani, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1418 Wyoming Ave, Scranton, PA 18509 Phone: 570-341-9730    Fax: 570-341-9731

Mr. Julio A Ramos, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 501 Madison Ave, Scranton, PA 18510 Phone: 570-343-2383    Fax: 570-230-0013

Emily Keeler, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7351    Fax: 570-703-7801

Mrs. Nevena Barjaktarovic, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 501 S Washington Ave # 1000, Scranton, PA 18505 Phone: 570-941-0630

News Archive

Low-skilled workers to perform initial blood donor screening: ONA, CFNU question decision

The Ontario Nurses' Association (ONA) has joined the Canadian Federation of Nurses Unions (CFNU) in questioning the decision of federal health minister Leona Aglukkaq to allow Canadian Blood Services to conduct a pilot project to replaces nurses with low-skilled workers for initial blood donor screening.

Different perspective on World Health Report 2000 on health systems

Martin McKee, Professor of European Health at the London School of Hygiene & Tropical Medicine has contributed one of three commentaries appearing today in the journal Health Policy and Planning, each of which take a different perspective on the World Health Report 2000 on health systems (WHR2000).

Santaris Pharma, Pfizer expand RNA-targeted medicine collaboration

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, and Pfizer Inc., today announced that the companies have expanded their collaboration directed to the development and commercialization of RNA-targeted medicines using Santaris Pharma A/S Locked Nucleic Acid (LNA) Drug Platform.

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

Read more Medical News

› Verified 7 days ago